BE
BE · BE · BE-AMP-SAM506533-00
Uptravi 1200 µg
ATC B01AC27
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerJanssen-Cilag International
CountryBE (BE)
ATC codeB01AC27
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 2
- be_apb7718810
- be_apb3450970
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Uptravi 1200 µg",
"name_fr": "Uptravi 1200 µg",
"name_nl": "Uptravi 1200 µg",
"amp_code": "SAM506533-00",
"strengths": [
"1200.0000"
],
"pack_count": 1,
"substances": [
"Selexipag"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Selexipag",
"authorisation_numbers": [
"EU/1/15/1083/008"
]
}Related drugs
Other records sharing ATC code B01AC27.
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
- 🇺🇸SelexipagZydus Lifesciences Limited
- 🇺🇸SelexipagZydus Pharmaceuticals (USA) Inc.
Access this data programmatically
Query Uptravi 1200 µg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.